|
||
|
Xenome Limited
Download PDF Members: Xenome aims to develop new treatments for pain, particularly intractable pain as experienced by many cancer patients, as well as other neurological conditions for which there is an unmet clinical need, e.g stroke.Xenome has an exclusive license to a collection of molecules and related technologies discovered by the Centre for Drug Design and Development (the Centre) at the University of Queensland (now part of the Institute for Molecular Bioscience). These molecules, know as conotoxins, were isolated from the venom of several species of cone shells collected from the Great Barrier Reef and have been shown to selectively inhibit proteins known as ion-channels. Inhibition of certain ion-channels is known to control various types of pain.
This page has been viewed 346 times since April 2007, the link to the organisation's website has been followed 65 times Recent Search Terms used to find this page: XENOME LIMITED | xenome limited | xenome 2008 | xenome 2008 | xenome biopharma | xenome | . This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Xenome Limited | ||||||||||||||||||||||||||||||||||||||||||||||||||
Nothing in this website should be used in place of personal medical
advice from your own qualified medical practitioner. See
User
Agreement |
All rights reserved. All other trademarks recognized. |
|
|